Latest Breaking News On - Sharon bio - Page 1 : vimarsana.com

Innova Captab makes flat start at Rs 456 against IPO price of Rs 448

The Rs 570-crore public issue of pharmaceutical company had received good response from investors with a subscription of 55.26 times during December 21-26. Qualified institutional buyers (QIBs) bought 116.73 times the portion set aside for them

Will Innova Captab see double-digit gains on debut?

Innova Captab is set to debut on the bourses on December 29. This is going to be the last mainboard listing for the current calendar year

IPO: Innova Captab may be a good buy after a post-listing review

The promoters Manoj Kumar Lohariwala and his brother Vinay Kumar Lohariwala are diluting their stakes from 67% to 52%. Of the issue proceeds, ₹168 crore would be used toward debt repayment and ₹72 crore for working capital requirements.

Innova Captab IPO: Should you subscribe to the Rs 570-crore issue?

Innova Captab IPO: Ahead of the debut, the pharmaceutical company mobilised Rs 171 crore from several anchor investors

Cyril Amarchand Mangaldas advises on CIRP of Sharon Bio-Medicine